journal cover

Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study

Depression and Anxiety

Jul 27, 2004

J R DavidsonHongjie Zheng

Download from

Publisher
PubMed

Abstract

Escitalopram has been shown in clinical trials to improve anxiety symptoms associated with depression, panic disorder, and social anxiety disorder. This study was designed to evaluate the efficacy and tolerability of escitalopram in the treatment of generalized anxiety disorder (GAD). O...read more

Mentioned in this Paper

Drug Tolerance
Adverse Event
Panic Disorder 1
Measurement of Human Anti-mouse Antibody
Outpatients
Anxiety Disorders
Selective Serotonin Reuptake Inhibitors
Anxiety States, Neurotic
Clinical Trial [Publication Type]
Dose-Response Relationship, Drug
79
Paper Details
References
  • References23
  • Citations67
123
  • References23
  • Citations67
12345...

Feeds With Similar Papers

Panic Disorders

Panic disorders include overwhelming panic attacks that are often spontaneous and not triggered by a particular event or situation. Treatment often includes pharmacotherapy, cognitive-behavioral therapy and psychodynamic therapy. Discover the latest research on panic disorders here.

Depression

Depression, also known as major depressive disorder, is a medical condition associated with negative emotional, behavioural, and cognitive symptoms. Here is the latest research on this mood disorder.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Related Papers

The International Journal of Neuropsychopharmacology

Prevention of relapse in generalized anxiety disorder by escitalopram treatment

The International Journal of NeuropsychopharmacologyDecember 1, 2005
Christer AllgulanderAnna Karina Trap Huusom
© 2020 Meta ULC. All rights reserved

Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study

Depression and Anxiety

Jul 27, 2004

J R DavidsonHongjie Zheng

PMID: 15274172

DOI: 10.1002/da.10146

Abstract

Escitalopram has been shown in clinical trials to improve anxiety symptoms associated with depression, panic disorder, and social anxiety disorder. This study was designed to evaluate the efficacy and tolerability of escitalopram in the treatment of generalized anxiety disorder (GAD). O...read more

Mentioned in this Paper

Drug Tolerance
Adverse Event
Panic Disorder 1
Measurement of Human Anti-mouse Antibody
Outpatients
Anxiety Disorders
Selective Serotonin Reuptake Inhibitors
Anxiety States, Neurotic
Clinical Trial [Publication Type]
Dose-Response Relationship, Drug
79

Feeds With Similar Papers

Panic Disorders

Panic disorders include overwhelming panic attacks that are often spontaneous and not triggered by a particular event or situation. Treatment often includes pharmacotherapy, cognitive-behavioral therapy and psychodynamic therapy. Discover the latest research on panic disorders here.

Depression

Depression, also known as major depressive disorder, is a medical condition associated with negative emotional, behavioural, and cognitive symptoms. Here is the latest research on this mood disorder.

Related Papers

The International Journal of Neuropsychopharmacology

Prevention of relapse in generalized anxiety disorder by escitalopram treatment

The International Journal of NeuropsychopharmacologyDecember 1, 2005
Christer AllgulanderAnna Karina Trap Huusom
Paper Details
References
  • References23
  • Citations67
123
  • References23
  • Citations67
12345...

Download from

Publisher
PubMed
/papers/escitalopram-in-the-treatment-of-generalized/15274172